Artículos por temáticas

Acute cholinergic syndrome in a patient taking the prescribed dose of donepezil for Alzheimer's disease

Hanazawa T, Kamijo Y, Yoshizawa T, Fujita Y, Usui K, Haga Y.

Psychogeriatrics. 2020 Jul;20(4):538-539. doi: 10.1111/psyg.12531. Epub 2020 Feb 17.

The Effects of Probiotics and Prebiotics on Mental Disorders: A Review on Depression, Anxiety, Alzheimer, and Autism Spectrum Disorders

Ansari F, Pourjafar H, Tabrizi A, Homayouni A.

Curr Pharm Biotechnol. 2020;21(7):555-565. doi: 10.2174/1389201021666200107113812.

Anti-interleukin-17A and anti-interleukin-23 antibodies may be effective against Alzheimer's disease: Role of neutrophils in the pathogenesis

Katayama H.

Brain Behav. 2020 Jan;10(1):e01504. doi: 10.1002/brb3.1504. Epub 2019 Dec 17.

Review of beneficial effects of resveratrol in neurodegenerative diseases such as Alzheimer's disease

Komorowska J, Wątroba M, Szukiewicz D.

Adv Med Sci. 2020 Sep;65(2):415-423. doi: 10.1016/j.advms.2020.08.002. Epub 2020 Aug 29.

Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia

Wang S, Temkin-Greener H, Conwell Y, Cai S.

J Am Med Dir Assoc. 2020 Nov;21(11):1617-1622.e3. doi: 10.1016/j.jamda.2020.04.005. Epub 2020 Jun 9.

Status and future directions of clinical trials in Alzheimer's disease

Plascencia-Villa G, Perry G.

Int Rev Neurobiol. 2020;154:3-50. doi: 10.1016/bs.irn.2020.03.022. Epub 2020 Jul 20.

Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer's Disease

Wu AJ, Tong BC, Huang AS, Li M, Cheung KH.

Curr Alzheimer Res. 2020;17(4):329-343. doi: 10.2174/1567205016666191210091302.

Targeting Tau Hyperphosphorylation via Kinase Inhibition: Strategy to Address Alzheimer's Disease

Turab Naqvi AA, Hasan GM, Hassan MI.

Curr Top Med Chem. 2020;20(12):1059-1073. doi: 10.2174/1568026620666200106125910.

GIP has neuroprotective effects in Alzheimer and Parkinson's disease models

Zhang ZQ, Hölscher C.

Peptides. 2020 Mar;125:170184. doi: 10.1016/j.peptides.2019.170184. Epub 2019 Nov 6.

Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques

Zhu X , Victor TW , Ambi A , Sullivan JK , Hatfield J , Xu F , Miller LM , Van Nostrand WE .

Metallomics. 2020 Apr 1;12(4):539-546. doi: 10.1039/c9mt00306a. Epub 2020 Feb 27.

Pharmacogenomics of Alzheimer's and Parkinson's diseases

Cacabelos R.

Neurosci Lett. 2020 May 1;726:133807. doi: 10.1016/j.neulet.2018.09.018. Epub 2018 Sep 17.

Alzheimer's Disease and Functional Foods: An Insight on Neuroprotective Effect of its Combination

Hasnieza Mohd Rosli N, Mastura Yahya H, Shahar S, Wahida Ibrahim F, Fadilah Rajab N.

Pak J Biol Sci. 2020 Jan;23(5):575-589. doi: 10.3923/pjbs.2020.575.589.

Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease

Jia J, Wei C, Chen W, Jia L, Zhou A, Wang F, Tang Y, Xu L.

J Alzheimers Dis. 2020;74(1):199-211. doi: 10.3233/JAD-190940.

The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease

Maskery M, Goulding EM, Gengler S, Melchiorsen JU, Rosenkilde MM, Hölscher C.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520953041. doi: 10.1177/1533317520953041.

Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway

Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP.

Inflammopharmacology. 2020 Apr;28(2):385-400. doi: 10.1007/s10787-019-00681-7. Epub 2020 Jan 3.